FDA-Sponsor Interaction Could Increase Post-Pandemic With Virtual, In-Person Options

Scott Gottlieb says that some meetings should remain in-person, but with virtual options proven effective, the FDA could offer more opportunities to talk to sponsors.

virtual meeting
Sponsors could find the FDA increasingly available post-pandemic thanks to the success of virtual meetings. • Source: Alamy

Former Commissioner Scott Gottlieb wants the US Food and Drug Administration to use the lessons from virtual meetings to expand its interaction with sponsors when in-person sessions return.

Gottlieb said in-person meetings during the application review cycle remain important and should be re-established when conditions warrant. But he...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet